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Quinocarmycin/quinocarcin analog DX-52-1Ezrin/radixin/moesin (ERM) proteins are membrane-cytoskeleton linkers that also have roles in signal
transduction. Here we show that G protein-coupled receptor kinase 2 (GRK2) regulates membrane protrusion
and cell migration during wound closure in Madin-Darby canine kidney (MDCK) epithelial cell monolayers at
least partly through activating phosphorylation of radixin on a conserved, regulatory C-terminal Thr residue.
GRK2 phosphorylated radixin exclusively on Thr 564 in vitro. Expression of a phosphomimetic (Thr-564-to-
Asp) mutant of radixin resulted in increased Rac1 activity, membrane protrusion and cell motility in MDCK
cells, suggesting that radixin functions “upstream” of Rac1, presumably as a scaffolding protein. Phosphoryla-
tion of ERMproteinswas highest during themost active phase of epithelial cell sheetmigration over the course
of wound closure. In view of these results, we explored the mode of action of quinocarmycin/quinocarcin
analog DX-52-1, an inhibitor of cell migration and radixin function with considerable selectivity for radixin
over the other ERM proteins, ﬁnding that its mechanism of inhibition of radixin does not appear to involve
binding and antagonism at the site of regulatory phosphorylation.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Cell migration is involved in a range of normal and disease
processes, including embryonic development, immune function,
tissue repair, angiogenesis and tumor metastasis. A common way to
trigger cell migration is to mechanically perturb a cell monolayer
through “scratch wounding.” In woundedMadin-Darby canine kidney
(MDCK) epithelial cell monolayers, the cellsmove as a continuous unit
with active protrusive force generation distributed from the wound
edge to multiple rows of cells behind it in the moving cell sheet [1,2].
The migration of the MDCK cell sheet involves the Rho-family small
GTPase Rac [1], phosphoinositides [1], c-Jun N-terminal kinase [3], Raf
kinase inhibitor protein [4], ADP-ribosylation factor 6 [5,6] and
glycogen synthase kinase 3 [6]. While wound closure depends on
Rac activity, Rho and Cdc42, other members of the Rho GTPase family
(for reviews, see [7,8]), are not required inMDCK cell sheets forwound
closure itself, but they do regulate how evenly the wound edge
advances [1]. Closure of small wounds in MDCK cell monolayers is
driven exclusively by cell migration and not cell proliferation [2].
A semisynthetic derivative of the natural product quinocarmycin
(also known as quinocarcin), DX-52-1, inhibits cell migration during+1 860 486 2981.
teany).
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ll rights reserved.wound closure in MDCK cell monolayers with a half-maximal
inhibitory concentration for inhibition of wound closure at 24 h
post-wounding of 140 nM [9]. DX-52-1 inhibits the function of the
membrane-cytoskeleton linker protein radixin [9]. Radixin is a
member of the ezrin/radixin/moesin (ERM) protein family that
binds actin and membrane-associated proteins; ERM proteins are
important for formation of diverse actin-rich cell-surface structures
and also function in cell signaling (for reviews, see [10–15]). ERM
proteins may also have roles in tumor metastasis [16–18]. DX-52-1
perturbs both C-terminal interactions of radixin with actin and N-
terminal interactions of radixin with certain membrane proteins, such
as the cell adhesion protein CD44, the cell-surface receptor for
hyaluronic acid [9]. In addition, DX-52-1 also binds the multifunc-
tional carbohydrate-binding protein galectin-3, outside of its carbo-
hydrate-binding site, but with slower kinetics than it does radixin
[19].
In the inactive state, ERM proteins exist in a closed, auto-inhibited
conformation in which the N-terminal FERM (band 4.1 and ERM)
domain and C-terminal domain bind one another in a head-to-tail
manner, thereby preventing association with their respective binding
partners [10–13]). Activation of ERM proteins requires binding of the
FERM domain to phosphatidylinositol-4,5-bisphosphate (PIP2) fol-
lowed by phosphorylation of a regulatory C-terminal Thr residue (Thr
567 of ezrin, Thr 564 of radixin and Thr 558 of moesin). In the
activated open state, ERM proteins bind actin ﬁlaments and the
membrane via integral and peripheral membrane proteins, such as
CD43, CD44 and ERM-binding phosphoprotein 50 (EBP-50; also
known as Na+/H+ exchanger regulatory factor 1).
Fig. 1. GRK2 positively regulates wound closure. RNA interference-based silencing of
GRK2 expression delays wound closure in MDCK cell monolayers. Western blots of
whole-cell lysates from control and stable GRK2-knockdown cells (GRK2 knockdown)
probed with anti-GRK2 and anti-actin antibodies are shown above the bar graph,
demonstrating knockdown of GRK2. Mean percent wound closure values with standard
errors of the mean (SEM) are shown at three times post-wounding for the indicated
number of wounds from three independent experiments is shown in the graph. The
smaller difference between the values for control and GRK2-knockdown cells at 9 h is
due to the fact that wounds in the control monolayers had largely closed already by 9 h
for the size of wounds made in these experiments.
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on their regulatory C-terminal Thr residues, including Rho-kinase
[20-22], protein kinase Cα [23], protein kinase Cθ [24], myotonic
dystrophy kinase-related Cdc42-binding kinase [25], Nck-interacting
kinase [26] and G protein-coupled receptor (GPCR) kinase 2 (GRK2)
[27]. GRK2, also known as β-adrenergic receptor kinase 1, has been
shown to be involved in the regulation of ﬁbroblast and epithelial
cell migration [28]. Furthermore, phosphorylation of ezrin by GRK2
results in membrane rufﬂing in carcinoma cells [27].
In the present study, we provide evidence that GRK2 regulates
membrane protrusion and collective migration of a cell sheet during
wound closure in MDCK cell monolayers at least partly through
phosphorylation of ERM proteins, in particular radixin, and eliminate
a possible mechanism for DX-52-1 involving antagonistic binding to
the site of phosphorylation by GRK2 on radixin.
2. Materials and methods
2.1. Cell culture
MDCK cells were purchased from the American Type Culture
Collection and were maintained in a growth medium consisting of
minimum essential medium (MEM) from Invitrogen with 10%
newborn calf serum (HyClone) and in Dulbecco's modiﬁed Eagle's
medium supplemented with 10% fetal bovine serum (Cellgro),
respectively. Cells were incubated in a tissue culture incubator at
37 °C and 5% CO2.
2.2. Antibodies
Goat anti-radixin antibody (sc-6408), mouse anti-hemaglutinnin
(HA) antibody (sc-7392) and rabbit anti-GRK2 antibody (sc-562)
were from Santa Cruz Biotechnology, as were horseradish peroxidase
(HRP)-conjugated secondary antibodies. Rabbit anti-actin antibody
(A2066) was from Sigma. Mouse anti-Rac1 antibody (610650) and
mouse anti-Cdc42 antibody (610928) were from BD Biosciences/BD
Transduction Laboratories. Rabbit anti-phospho-ERM antibody
(3141) was from Cell Signaling Technology.
2.3. Silencing of GRK2 expression
Four target DNA sequences corresponding to nucleotides 568–588,
964–984, 1295–1315 and 1665–1685 relative to the start codon of the
canine GRK2 genewere chosenwith the siRNA Target Finder tool from
Ambion. Knockdown of GRK2 in MDCK cells was achieved with a
previously described short hairpin RNA (shRNA) expression vector [6]
transfected into cells with Lipofectamine (Invitrogen), according to
the manufacturer's instructions. Stable transfectants were selected in
400 μg/ml hygromycin (A.G. Scientiﬁc). There is an enhanced green
ﬂuorescent protein (GFP) expression cassette in the shRNA expres-
sion vector [6]. This allowed us to isolate GFP-positive stable
transfectants with a ﬂuorescence-activated cell sorter. Efﬁcient
knockdown (∼90%) of GRK2, based on Western blot analysis with
anti-GRK2 antibody, was achieved with the shRNA corresponding to
nucleotides 568–588 of canine GRK2. As a control, we used cells stably
transfected with the shRNA corresponding to nucleotides 964–984 of
GRK2, since we found no change in GRK2 protein levels by Western
blot analysis in these cells. Detection forWestern blot analysis in these
and subsequent experiments was with a species-appropriate HRP-
conjugated secondary antibody and chemiluminescence according to
the reagent manufacturer's procedure (GE Healthcare).
2.4. Fusion constructs and site-directed mutagenesis
Cloning of full-lengthmurine radixin in the pVL1392 vector and N-
terminal (amino acid residues 1–318) and C-terminal (residues 319–583) domains of murine radixin as glutathione-S-transferase (GST)
fusions in pGEX-2T have been described previously [9,29]. The GFP-
fusion construct of chicken radixin in pEGFP-N1 and the HA-fusion
construct of murine radixin in pMFG have also been previously
described [9,30]. The GST-fusion construct of human ezrin in pGEX-2T
[31] was provided by Christian Roy (Université de Montpellier,
France). The GST-fusion construct of human moesin in pGEX-4T1 [32]
was provided by Vijaya Ramesh (Massachusetts General Hospital).
Constructs for bovine wild-type GRK2 and the GRK2-K220Rmutant in
pcDNA3 [33,34] were provided by Philip B. Wedegaertner (Thomas
Jefferson University). The GST-fusion construct of the p21-binding
domain (PBD), which binds activated Rac1 and Cdc42, derived from
murine p21-activated kinase 3 (PAK3) and cloned into pGEX-KG [35]
was provided by Richard A. Cerione (Cornell University).
Site-directed mutagenesis was carried out with Stratagene's
QuikChange kit, following the manufacturer's instructions. The
sense oligonucleotide primers (with mutation sites underlined)
used for mutagenesis of murine radixin (fused to GST) were 5′-
GCCGTGATAAGTACAAGGCCCTTCGGCAGATTCG-3′ for the T564A mu-
tation, 5′-GGCCGTGATAAGTACAAGGACCTTCGGCAGATTCGACA-3′ for
the T564D mutation, 5′-CGGCAGATTCGACAAGGCAATGCGAAG-
CAGCGC-3′ for the T573A mutation. The sense primer used for the
T564D mutation of chicken radixin (fused to GFP) was 5′-
AGGCCGTGGTAAGTACAAGGATCTTCGACAAATCCGACAA-3′. Success
of mutation was veriﬁed by DNA sequencing.
2.5. Preparation of cells expressing different forms of radixin or GRK2
MDCK cells stably expressing GFP alone, GFP fusions of chicken
radixin or radixin-T564D or murine radixin-HA were prepared by
Lipefectamine-mediated transfection, followed by selection in
growth medium with 500 μg/ml G418 sulfate (Geneticin) from
Invitrogen. Transgene expression was conﬁrmed by ﬂuorescence
Fig. 2. Expression of wild-type radixin and constitutively active radixin results in increasedmembrane protrusion andmotility. (A) RepresentativeWestern blot of whole-cell lysates
fromMDCK cells stably expressing radixin-GFP (lane 1), constitutively active, phosphomimetic radixin-T564D-GFP mutant (lane 2) or radixin-HA (lane 4; the radixin-HA cells were
used in the experiment described in Fig. 7) probed with anti-radixin antibody. Lane 3 consists of non-transfected MDCK cells, showing expression of endogenous radixin alone. The
levels of expression were calculated from the intensity of bands on three separate Western blots as 222% for radixin-GFP, 137% for radixin-T564D-GFP and 112% for radixin-HA that
of endogenous radixin. (B) Fluorescence images of wounded monolayers of cells expressing GFP alone, radixin-GFP or radixin-T564D-GFP in the presence or absence of the radixin
inhibitor DX-52-1, as indicated. Conﬂuent monolayers of MDCK cells stably expressing GFP alone, radixin-GFP or radixin-T564D-GFP were wounded and then ﬁxed 6 h later and
processed for imaging. From left to right, each row consists of a differential interference contrast image, a ﬂuorescence image showing GFP ﬂuorescence and a second ﬂuorescence
image showing TRITC-phalloidin staining of ﬁlamentous actin. All images in B are at the same magniﬁcation, with the scale bar corresponding to 50 μm. (C) Higher magniﬁcation
ﬂuorescence images of wounded sheets of cells expressing radixin-T564D-GFP 6 h after wounding, showing aberrant morphology and protrusions. From left to right, each row
consists of a ﬂuorescence image showing GFP ﬂuorescence, a second ﬂuorescence image showing TRITC-phalloidin staining of ﬁlamentous actin and a merged image. All images in C
are at the same magniﬁcation, with the scale bar corresponding to 50 μm. (D) Lamellipodial density at the wound margin (number of lamellipodial membrane protrusions at the
wound edge divided by margin perimeter length) 6 h after wounding of monolayers of cells expressing GFP alone, radixin-GFP or radixin-T564D-GFP. Values are mean and SEM for
six wounds from three independent experiments. (E) Percent wound closure at 6 h post-wounding in monolayers of cells expressing GFP alone, radixin-GFP and radixin-T564D-GFP
in the presence or absence of DX-52-1 (mean and SEM for 12 wounds in each case from three independent experiments).
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fusion-expressing cells, GFP-positive cells were isolated with a
ﬂuorescence-activated cell sorter, while for radixin-HA-expressing
cells, the use of cloning disks and serial dilution allowed for isolation
of single transfectants. Transient transfection of GRK2 or GRK2-
K220R into the radixin-HA-expressing cells was also accomplished
with Lipofectamine.
2.6. Wound closure assay and quantitation of membrane protrusion
Early passages of MDCK cells thawed from frozen stock cultures
were used in all experiments. Wound closure experiments were
conducted essentially as previously described [36]. The cell sheets
were wounded with a micropipet ﬁtted with ultramicro tips, and
digital images of the wounded areas were acquired at different times
post-wounding. The images were imported into NIH ImageJ software
(http://rsbweb.nih.gov/ij/) for analysis. The numbers of membrane
protrusions around the wound edge were counted to determine
lamellipodial density at the margin (number of lamellipodial
membrane protrusions divided by wound-edge perimeter length) aspreviously described [3]. Cell viability was evaluated at the end of
each experiment by both the trypan blue dye exclusion assay and
observation of cell morphology, noting any rounding up and
detachment of cells.
2.7. Fluorescence microscopy
MDCK cells stably transfected with GFP alone or GFP-fusion
proteins were plated on glass coverslips in 12-well tissue culture
plates and grown to conﬂuence. Following wounding and incubation
for 6 h at 37 °C and 5% CO2, cells were ﬁxed with 4% formaldehyde and
permeabilized with 0.5% Triton X-100 in phosphate-buffered saline
(PBS) for 15 min. Cells were stained for ﬁlamentous actin with 50 nM
tetramethylrhodamine isothiocyanate-conjugated phalloidin (TRITC-
phalloidin; Sigma). Finally, after washing three times with PBS,
coverslips were mounted onto glass slides in Mowiol 4-88 (0.1 g/ml)
mounting medium (EMD Biosciences) containing 15 mg/ml of the
antifade agent 1,4-diazabicyclo[2.2.2]octane (Sigma). Images were
captured on an inverted ﬂuorescence microscope (Leica DMI 6000B),
equipped with a Hamamatsu Orca AG cooled charge-coupled device
Fig. 3. Rac1 activity is elevated in cells expressing constitutively active radixin. Pull-
down of activated GTP-bound Rac1 (A) and GTP-bound Cdc42 (B) was performed from
extracts prepared from MDCK cells expressing GFP alone (lane 1), radixin-GFP (lane 2)
or radixin-T564D-GFP (lane 3). Representative Western blots for activated and total
Rac1 and Cdc42 are shown, along with graphed data derived from quantitated band
intensities for three independent experiments (mean and SEM), with values expressed
as a percent of the levels of GTP-Rac1 or GTP-Cdc42 in control cells expressing GFP
alone (normalization to the parallel control for each experiment prior to statistics).
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2.8. Expression and puriﬁcation of recombinant proteins
Expression and puriﬁcation of full-length radixin from Sf9 cells
using the baculovirus expression system was accomplished as
previously described [9]. Since bacterial expression yields functional
full-length ERM proteins as well [9,20,31,32,37], we also used this
system for expression. GST-fusion proteins of radixinmutants (T564A,
T564D and T573A), radixin N-terminal fragment, radixin C-terminal
fragment, ezrin, moesin and PAK3 PBD were expressed in Escherichia
coli strain BL21(DE3). Single bacterial colonies were picked to seed
cultures in 500 ml of Luria-Bertani medium. After growing the
cultures overnight, isopropyl-D-thiogalactopyranoside was added to
0.2 mM, followed by incubation for 3 h. Cells were then collected by
centrifugation (5000 × g, 10 min). Bacterial pellets were resuspended
in 25-ml ice-cold PBS containing 2 mM ethylene diamine tetraacetic
acid (EDTA), 1 mM dithiothreitol (DTT), 100 μg/ml lysozyme, 0.5%
Triton X-100 and protease inhibitors [1 μg/ml leupeptin, 1 μg/ml
pepstatin A, 0.1 mM phenylmethysulfonyl ﬂuoride (PMSF) and
0.1 mM benzamidine]. Homogenized lysates were centrifuged
(15,000×g, 30 min, 4 °C), and the resulting supernatants were
mixed with 5 ml of a 1:1 slurry of glutathione-agarose beads (Sigma)
in PBS, then incubated on a rotating wheel for 2 h at 4 °C. Proteolytic
cleavage to release ERM proteins, fragments and point mutants from
the GST moiety was achieved by incubation with bovine thrombin
(Sigma) for 12 h at 4 °C in PBS, pH 7.4. Elution of GST-PBD was
performed with 50 mM Tris, pH 8.0, 150 mM NaCl, 2.5 mM CaCl2,
1 mM DTT and 10 mM glutathione. Purity of the resulting
recombinant proteins was determined by sodium dodecyl sulfate
(SDS)-polyacrylamide gel electrophoresis and staining with Coomas-
sie blue.
2.9. Pull-down assays
The amount of GTP-bound Rac1 and Cdc42 was determined by an
afﬁnity pull-down assay with immobilized GST-PBD fusion protein, as
previously described [6,38]. Equal amounts of whole-cell lysates from
MDCK cells stably expressing GFP, radixin-GFP or radixin-T564D-GFP
were incubated in RIPA buffer (50 mM Tris, pH 7.4, 150 mM NaCl,
1 mM EDTA, 0.5% sodium deoxycholate, 1% Nonidet P-40, 0.1% SDS,
2 mM DTT, 1 μg/ml leupeptin, 1 μg/ml pepstatin A, 0.1 mM PMSF,
0.1 mMbenzamidine and 100 μM sodium orthovanadate) with ∼20 μg
GST-PBD and 30 μl glutathione-agarose beads on a rotating wheel for
2 h at 4 °C. Following three cycles of washing in the same buffer to
remove unbound proteins, with centrifugation (5000 × g, 5 min)
between each wash to collect the beads, bound proteins were eluted
from the beads with 30 μl of 2× SDS sample buffer. After boiling,
samples were subjected to SDS-polyacrylamide gel electrophoresis
and Western blot analysis with anti-Rac1 or anti-Cdc42 antibody. The
levels of total Rac1 or Cdc42 were also determined by Western blot
analysis.
2.10. Kinase assays
Puriﬁed baculovirally expressed GRK2 protein was provided by
Robert J. Lefkowitz (Duke University Medical Center). The kinase
activity of GRK toward puriﬁed recombinant ERM proteins, radixin
point mutants, radixin N-terminal fragment and radixin C-terminal
fragment as substrates was determined in a standard in vitro kinase
assay. The reactions were performed in kinase buffer (20 mM Tris, pH
7.5, 150 mM NaCl, 10 mM MgCl2, 0.5 mM EDTA, 0.5 mM ethylene
glycol tetraacetic acid, 2 mM DTT, 1 μg/ml leupeptin, 1 μg/ml
pepstatin A, 0.1 mM PMSF, and 0.1 mM benzamidine) with 200 nM
GRK2, each substrate (1 μM of the full-length proteins or 2 μM of thetruncated proteins), 50 μM ATP and 2 μCi [γ-32P]-ATP (PerkinElmer)
in the presence or absence of 25 μM porcine brain L-α-phosphatidy-
linositol-4,5-bisphosphate (PIP2; Avanti Polar Lipids) and/or 50 nM
bovine brain G protein βγ subunits (EMD Biosciences) in a ﬁnal
volume of 50 μl for 60 min at 30 °C. The reactions were terminated by
adding 25 μl of 2× SDS sample buffer followed by boiling for 5 min.
Protein samples were resolved by SDS-polyacrylamide gel electro-
phoresis, and phospho-protein bands were visualized with a Bio-Rad
Personal Molecular Imager.
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MDCK cells were seeded in growth medium in 100-mm diameter
tissue culture-treated polystyrene dishes and grown to conﬂuence;
the medium was then replaced with serum-free MEM for 24 h. After
adding fresh medium, the monolayers were multiply wounded with
plastic pipet tips, with 30 wounds across each plate. At the indicated
times after wounding, cells were washed three times with ice-cold
PBS and then lysed with 350 μl per plate of 2× SDS sample buffer. The
whole-cell lysates were boiled for 10 min and centrifuged (15 min,
15,000 × g) prior to SDS-polyacrylamide gel electrophoresis and
Western blot analysis. Blots were probed with anti-phospho-ERM
antibody, then stripped and reprobed with anti-radixin antibody.
The same procedure was followed for the analysis of phospho-ERM
levels in MDCK cells transiently transfected with different GRK2
constructs.Fig. 4. GRK2 phosphorylates the C-terminal region of radixin in vitro. (A) Kinase assays wer
lanes 1, 2, 3 and 4), N-terminal radixin fragment (N; lanes 5, 6, 7 and 8) and C-terminal radix
PIP2 (lanes 2, 4, 6, 8, 10 and 12) or Gβγ subunits (lanes 3, 4, 7, 8, 11 and 12). [γ-32P]-ATP-labe
protein is shown for equivalent loadings at the bottom. (B) Levels (mean and SEM) of [
experiments as in A are shown, with values expressed as a percent of the level of phosphoryla
to the parallel full-length radixin result for each experiment prior to statistics).2.12. DX-52-1-binding assay
The assay for DX-52-1 binding was performed as described
previously [9,19]. Puriﬁed recombinant full-length radixin and its
mutants (T564A, T564D and T573A), as well as ezrin andmoesin were
all tested under identical conditions: 20 μM protein solution (in a
buffer of 20 mM Tris, pH 7.4, 150 mM NaCl, 2 mM EDTA, 2 mM DTT,
0.5% Triton X-100, 1 μg/ml leupeptin, 1 μg/ml pepstatin A, 100 μM
PMSF and 100 μM benzamidine) with 10 μM biotinylated DX-52-1
with or without 50× molar excess of free, non-biotinylated DX-52-1
added simultaneously. After incubation at 4 °C for 4 h, an equal
volume of 2× SDS sample buffer was added to each sample, followed
by SDS-polyacrylamide gel electrophoresis and transfer to a poly-
vinylidene ﬂuoride membrane as in conventional Western blotting.
Detection of biotinylated DX-52-1-labeled proteins was achievedwith
streptavidin-HRP (Sigma) and chemiluminescence.e performed with puriﬁed recombinant GRK2 and recombinant full-length radixin (FL;
in fragment (C; lanes 9, 10, 11 and 12), in the absence (lanes 1, 5 and 9) or presence of
led protein is shown in the autoradiogram at the top, while total Coomassie blue-stained
γ-32P]-ATP-labeled protein quantitated from autoradiograms from four independent
tion of full-length radixin alone (without PIP2 or Gβγ subunits) by GRK2 (normalization
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3.1. GRK2 positively regulates cell sheet migration during wound closure
We investigated the effect of silencing of GRK2 expression by
stable transfection of a GRK2-speciﬁc shRNA cloned into a previously
described shRNA expression vector [6]. The shRNA consisted of a
hairpin loop and the sequence corresponding to positions 568–588
relative to the start codon of the canine GRK2 gene. The efﬁciency of
GRK2 knockdown in the stably transfected cells was ∼90% byWestern
blot analysis (Fig. 1). We found that the GRK2-knockdown cells
migrated more slowly than control cells during wound closure
(Fig. 1). This result suggests a positive role for GRK2 in the regulation
of cell sheet migration during wound closure in MDCK cell mono-
layers, consistent with the results reported by Penela et al. [28].
3.2. Expression of a phosphomimetic radixin mutant increases
membrane protrusion and motility
Phosphorylation of Thr 564 on radixin inhibits the association of its
N- and C-terminal domains and results in conformational unmasking
of its actin and membrane protein-binding ability (for reviews, see
[10–13]). Mutation of Thr 564 to a negatively charged residue, Asp orFig. 5. GRK2 phosphorylates radixin on Thr 564 in vitro. (A) Kinase assays were performed
radixin-T564A mutant (lane 2), non-phosphorylatable radixin-T573A mutant (lane 3), con
fragment (lane 5), C-terminal radixin fragment (lane 6), ezrin (lane 7) and moesin (lane
Coomassie blue-stained protein is shown for equivalent loadings at the bottom. (B) Levels (
three independent experiments as in A are shown, with values expressed as a percent of the
parallel wild-type radixin result for each experiment prior to statistics).Glu, has been shown to result in a constitutively active phosphomi-
metic protein [39,40]. To examine the functional signiﬁcance of the
phosphorylation state of Thr 564 of radixin on epithelial cell sheet
migration during wound closure, we prepared a mammalian
expression construct encoding GFP fused to a radixin Thr-564-to-
Asp mutant (radixin-T564D). We transfected this construct into
MDCK cells and selected for stable expression, conﬁrmed by
ﬂuorescence microscopy and Western blot analysis (Fig. 2A).
We examined the effect of expression of the phosphomimetic
radixin-T564D-GFP construct on MDCK cell morphology and migra-
tion following wounding of conﬂuent monolayers. Cells expressing
radixin-T564D-GFP displayedmarkedly increased levels of membrane
protrusion and aberrant morphology compared to the control GFP-
expressing cells (Fig. 2B–D). While less pronounced, the level of
protrusive activity was also higher relative to the radixin-GFP-
expressing cells, as quantitated in Fig. 2D. The high protrusive activity
in the radixin-T564D-GFP-expressing cells was suppressed by
treatment with the radixin inhibitor DX-52-1 (Fig. 2B). Wound
closure by radixin-T564D-GFP-expressing cells was considerably
faster than by control GFP-expressing cells and slightly faster than
by radixin-GFP-expressing cells (Fig. 2E). In addition, expression of
radixin-T564D-GFP resulted in loss of sensitivity of cells to the
antimigratory activity of the radixin inhibitor DX-52-1 (Fig. 2E), as didwith puriﬁed recombinant GRK2 and wild-type radixin (lane 1), non-phosphorylatable
stitutively active, phosphomimetic radixin-T564D mutant (lane 4), N-terminal radixin
8). [γ-32P]-ATP-labeled protein is shown in the autoradiogram at the top, while total
mean and SEM) of [γ-32P]-ATP-labeled protein quantitated from autoradiograms from
level of phosphorylation of full-length wild-type radixin by GRK2 (normalization to the
Fig. 6. Phosphorylation of ERM proteins increases during the most active migratory
phase of wound closure. (A) Phospho-ERM levels are shown on a representative
Western blot probed with anti-phospho-ERM antibody at the top for an unwounded
monolayer (lane 1) and at the following times after wounding: 5 min (lane 2), 15 min
(lane 3), 1 h (lane 4), 3 h (lane 5) and 6 h (lane 6). The same blot stripped and reprobed
with anti-radixin antibody is shown at the bottom. (B) Levels (mean and SEM) of ERM
phosphorylation as a function of time after wounding are shown, derived from band
intensities on Western blots for three separate experiments as in A, with values
expressed as a percent of the level of phospho-ERM in unwounded monolayers
(normalization to the parallel unwounded monolayer for each experiment prior to
statistics).
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radixin-T564D-GFP can titrate free DX-52-1 and reduce its effective-
ness, just as radixin-GFP does, and implies that Thr 564 is not the site
of alkylation of radixin by DX-52-1, something explored further later
in this study.
3.3. Rac1 activity but not Cdc42 activity is elevated in
radixin-T564D-GFP-expressing cells
Since expression of constitutively active radixin mutant in MDCK
cells caused pronounced membrane protrusions at the wound edge,
the levels of activated (GTP-bound) Rac1 and Cdc42were evaluated. A
pull-down assay with a GST-PBD fusion [6,38], which speciﬁcally
binds to the GTP-bound forms of these small GTPases, was performed
with MDCK cell extracts prepared from cells expressing GFP alone,
radixin-GFP or radixin-T564D-GFP. Both activated and total protein
levels were determined by Western blot analysis with anti-Rac1 and
anti-Cdc42 antibodies. The level of activated Rac1 in the radixin-
T564D-GFP-expressing cells was markedly elevated above the con-
trols, whereas the level of activated Cdc42 was unchanged (Fig. 3).
Although the mechanism is currently unknown, radixin appears to
lie in a signaling pathway, presumably as a scaffolding protein,
“upstream” of Rac1, a conjecture supported by other studies [41, 42].
ERM proteins may function both by regulating and being regulated by
Rho-family GTPases in a positive feedback loop (for reviews, see
[43,44]). The Rho GDP dissociation inhibitor directly associates with
ERM proteins, resulting in activation of Rho proteins [45]. At the same
time, Rho proteins regulate ERM proteins, such as by positively
affecting the interaction of ERM proteins with CD44 [46,47]. CD44
itself interacts with the guanine nucleotide exchange factor Tiam1
and stimulates Rac1 signaling [48]. The results collectively suggest
that ERM proteins directly and indirectly participate in localized
signaling feedback loops near the plasmamembrane that are involved
in cell adhesion, actin dynamics and cell migration. Our data suggest
another possible feature of this process, whereby ERM proteins and
their membrane-bound binding partners like CD44may cooperatively
regulate Rac1 signaling.
3.4. GRK2 phosphorylates the C-terminal region of radixin
A number of kinases have been reported to mediate the
phosphorylation of ERM proteins at their regulatory C-terminal Thr
residues [21–27]. GRK2 has been shown to phosphorylate Thr 567 of
ezrin and regulate membrane rufﬂing in carcinoma cells [27]. GRKs
are best understood as kinases that phosphorylate agonist-occupied
GPCRs, allowing for the binding of β-arrestins to GPCRs, which
prevents further GPCR signaling and results in their desensitization to
agonist (for reviews, see [49–51]). However, GRK2 also regulates a
range of other proteins, including synucleins [52], phosducin [53],
ribosomal protein P2 [54], the inhibitory γ subunit of the type 6
retinal cyclic guanosine monophosphate phosphodiesterase [55], the
β subunit of the epithelial Na+ channel [56], tubulin [57–59] and ezrin
[27]. The role of GRK2 in epithelial cell motility is likely to be related to
its ability to regulate non-GPCR proteins relevant to cell migration
such as tubulin or ezrin.
We investigated the phosphorylation of full-length radixin and N-
and C-terminal radixin fragments by GRK2 in the presence or absence
of PIP2 and G protein βγ subunits. PIP2 affects the conformation of
ERM proteins, opening them to their active state in which they can
interact with their binding partners [47,60–62]. In addition, PIP2
separately activates GRK2 [63]. Gβγ subunits are also activators of
GRK2 [64,65]. Puriﬁed recombinant GRK2 robustly phosphorylated
recombinant full-length radixin even in the absence of any GRK2
activator in vitro, and we saw very slight-to-no enhancement in the
presence of activators (Fig. 4A and B). Under these conditions, the
recombinant GRK2 was therefore activated to a near maximal level.The C-terminal radixin fragment (amino acid residues 319–583) was
also phosphorylated by GRK2, whereas the N-terminal radixin
fragment (residues 1–318) was not phosphorylated.
3.5. Radixin is phosphorylated by GRK2 exclusively on Thr 564
Radixin has two Thr residues near its C-terminal end, Thr 564 and
Thr 573. To deﬁnitively establish that Thr 564 is the regulatory Thr
residue phosphorylated by GRK2, we performed site-directed muta-
genesis. Three mutants were generated—radixin-T564A, radixin-
T573A and the phosphomimetic radixin-T564D—and then expressed
and puriﬁed. The phosphorylation of these radixin mutants, the N-
and C-terminal radixin fragments, moesin and ezrin by GRK2 was
assessed. Challenging recombinant GRK2 with radixin-T564A or
radixin-T564D as substrates resulted in little or no phosphorylation
(Fig. 5A, lanes 2 and 4, respectively). The N-terminal fragment of
radixin was not phosphorylated either (Fig. 5A, lane 5). In contrast,
radixin-T573A, the C-terminal radixin fragment, ezrin and moesin
were effective substrates for GRK2 (Fig. 5A, lanes 3, 6, 7 and 8,
respectively). The quantitated values from triplicate experiments are
shown in Fig. 5B. The results demonstrate that Thr 546 is the exclusive
site of phosphorylation of radixin by GRK2.
3.6. Phosphorylation of ERM proteins increases during the most active
migratory phase of wound closure
In order to understand the functional importance of GRK2-
mediated phosphorylation of the regulatory Thr residue of ERM
proteins, particularly radixin, we examined the changes in phosphor-
ylation state of ERM proteins before and after wounding of conﬂuent
MDCK cell monolayers by Western blot analysis with an anti-
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phorylated on their regulatory C-terminal Thr residues: Thr 567 for
ezrin, Thr 564 for radixin and Thr 558 for moesin). As shown in Fig. 6A
and B, the level of phosphorylated ERM was low in the unwounded
monolayer and just after wounding. However, phosphorylation began
to increase by 15 min post-wounding. High levels of phosphorylated
ERMproteins were observed 1, 3 and 6 h after wounding, whenMDCK
cells extendmembrane protrusions and activelymigrate into the open
area left by the wound.
3.7. GRK2-dependent phosphorylation of ERM proteins in MDCK cells
We asked whether GRK2 activity is sufﬁcient to induce the
phosphorylation of ERM proteins in MDCK cells. The role of GRK2 in
the activation of ERM proteins was evaluated by transiently
transfecting radixin-HA-expressing MDCK cells with empty vector
as a control, wild-type GRK2, kinase-dead GRK2 (GRK2-K220R) or
GRK2-speciﬁc shRNA. Whole-cell lysates were prepared and sub-
jected to Western blot analysis to determine the levels of phosphor-
ylated ERM proteins with the anti-phospho-ERM antibody. Even
though GRK2 appears ubiquitously expressed in MDCK cells by
immunoﬂuorescent staining (data not shown), transient overexpres-
sion of GRK2 still resulted in an increase in levels of phosphorylated
ERM proteins compared to the control cells transfected with empty
vector (Fig. 7A and B). In contrast, knockdown of GRK2 or expression
of kinase-dead GRK2 resulted in decreased levels of phosphorylated
ERM proteins. The total levels of radixin remained unaffected, as
determined by reprobing the same blots with the anti-radixin
antibody. The degree of ERM-protein phosphorylation was lowest in
the GRK2-knockdown cells, although some phosphorylation was stillFig. 7. GRK2-dependent phosphorylation of ERM proteins in MDCK cells. (A) A
representative Western blot probed with phospho-ERM antibody is shown at the top
for extracts from conﬂuent MDCK cell cultures stably expressing radixin-HA that were
then transiently transfected with empty vector (lane 1), wild-type GRK2 (lane 2),
kinase-dead GRK2-K220R mutant (lane 3) or GRK2-speciﬁc shRNA (GRK2 knockdown;
lane 4). The same blot stripped and reprobed with anti-radixin antibody is shown at the
bottom. (B) Levels (mean and SEM) of phosphorylated ERM proteins are shown,
derived from band intensities on Western blots for three separate experiments as in A
and expressed as a percent of the level for empty vector controls (normalization to the
parallel control for each experiment prior to statistics).observed, presumably as a result of the activity of other kinases that
can phosphorylate the C-terminal regulatory Thr residues of ERM
proteins, such as Rho-kinase [20–22], protein kinase Cα [23], protein
kinase Cθ [24], myotonic dystrophy kinase-related Cdc42-binding
kinase [25] and Nck-interacting kinase [26].
3.8. Thr 564 and Thr 573 are not the sites of modiﬁcation by DX-52-1 on
radixin, and ezrin and moesin are also modiﬁed by DX-52-1, but much
less intensely than radixin
We previously showed that DX-52-1 binds the C-terminal region
of radixin in a saturable and speciﬁc manner, disrupting interactions
with both actin and CD44 [9]. The interaction with actin and CD44 is
mediated by the C-terminal and N-terminal regions of radixin,
respectively (for reviews, see [10–15]). The structural effects of DX-
52-1 on radixin appear complex, involving both short-range steric or
conformational changes and long-range conformational changes. A
possibility is that DX-52-1 may act by alkylating one of the C-terminal
Thr residues, particularly the GRK2-phosphorylated Thr 564 residue.Fig. 8. Thr 564 and Thr 573 are not the sites of modiﬁcation by DX-52-1 on radixin, and
ezrin and moesin are also modiﬁed by DX-52-1, but much less intensely than radixin.
(A) DX-52-1 binds the Thr-to-Ala radixin mutants (radixin-T564A and radixin-T573A),
along with wild-type radixin, but only very weakly binds ezrin and moesin. DX-52-1-
binding experiments were performed as described in Materials and methods with
20 μM of each puriﬁed recombinant protein and 10 μM biotinylated DX-52-1 with or
without 500 μMof free, unlabeled DX-52-1 (added simultaneously to verify saturability
and speciﬁcity). Proteins and treatments are: wild-type radixin, biotinylated DX-52-1
(lane 1); wild-type radixin, biotinylated DX-52-1 (BD) with 50× free, unlabeled DX-52-
1 (D; lane 2); radixin-T564A, biotinylated DX-52-1 (lane 3); radixin-T564A,
biotinylated DX-52-1 with 50× DX-52-1 (lane 4); radixin-T573A, biotinylated DX-52-
1 (lane 5); radixin-T573A, biotinylated DX-52-1 with 50× DX-52-1 (lane 6); ezrin,
biotinylated DX-52-1 (lane 7); ezrin, DX-52-1 with 50× DX-52-1 (lane 8); moesin,
biotinylated DX-52-1 (lane 9); moesin, biotinylated DX-52-1 with 50× DX-52-1 (lane
10). (B) DX-52-1 does not block phosphorylation of radixin by GRK2. Puriﬁed
recombinant GRK2 was preincubated with different concentrations of DX-52-1,
followed by assay of kinase activity toward radixin, as described in Materials and
methods. Levels (mean and SEM) of [γ-32P]-ATP-labeled radixin were quantitated from
autoradiograms from three independent experiments, with values expressed as a
percent of the level of the phosphorylated radixin signal for DMSO controls
(normalization to the parallel control for each experiment prior to statistics).
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the two Thr-to-Ala radixin mutants (radixin-T564A and radixin-
T573A), where the nucleophilic Thr residues are converted to non-
nucleophilic Ala residues, which cannot be phosphorylated or
modiﬁed by DX-52-1. Mutation of Thr 564 or Thr 573 on radixin to
Ala did not affect binding of biotinylated DX-52-1 (Fig. 8A), consistent
with the results shown in Fig. 2E, where expression of radixin-T564D-
GFP in cells led to decreased sensitivity to DX-52-1, as did radixin-GFP
(Fig. 2E and [9]). The results suggest that whatever nucleophile on
radixin is speciﬁcally modiﬁed by DX-52-1, it is not one of these two
Thr residues. We also evaluated the effect of DX-52-1 on phosphor-
ylation of radixin by GRK2. Only a slight decrease in the phosphor-
ylation of radixin was observed at high concentrations of DX-52-1
(Fig. 8B), which could be the result of some non-speciﬁc alkylation.
These data suggest that the primary site of modiﬁcation of radixin by
DX-52-1 is not the site of phosphorylation by GRK2. Ultimately, this
appears consistent with our previous result that DX-52-1 does not
disrupt interactions with EBP-50 [9], since if DX-52-1 were blocking
activating phosphorylation of ERM proteins, one would expect all
interactions of activated ERM proteins to be affected.
We also found that both ezrin and moesin were labeled by
biotinylated DX-52-1, though far less intensely than is radixin (Fig.
8A). Compared to binding to radixin, binding was much weaker to
ezrin and weaker still to moesin. These results suggest that
biotinylated DX-52-1 binds ezrin and moesin far more slowly than
it does radixin. The data are also consistent with our initial
identiﬁcation of radixin as the major binding protein for biotinylated
DX-52-1 following unbiased, afﬁnity-guided puriﬁcation from MDCK
cell extracts [9] and demonstrate that DX-52-1 exhibits considerable
selectivity for radixin over the other ERM proteins.Acknowledgements
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